Previous close | 0.0000 |
Open | 0.2300 |
Bid | 0.2000 x 0 |
Ask | 0.3100 x 0 |
Day's range | 0.2300 - 0.2300 |
52-week range | 0.0160 - 0.3500 |
Volume | |
Avg. volume | 7,879 |
Market cap | 2.043M |
Beta (5Y monthly) | -0.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Integrated Service Program (ISP) Revenues Surge 268% in Q1 2024 Over Q1 2023 WEST PALM BEACH, FL, May 13, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today released detailed financial results for the first quarter ended March 31, 2024, showcasing not only revenue growth but also significant reductions in operating expenses and a posit
WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced the appointment of Dr. Marcos Sanchez-Gonzalez as the new Vice President of Medical and Scientific Affairs. Strategic Role and Objectives: In his new role, Dr. Sanchez-Gonzalez will spearhead the development, management, and execution of comprehen
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended March 31, 2024. Financial Highlights: ●First Quarter Revenues were $488,587, a 38% increase over the $352,799 reported in the first quarter of 2023. ●First Quarter Gross Profit was $2